Discriminating between cell surface and intracellular plasminogen-binding proteins: Heterogeneity in profibrinolytic plasminogen-binding proteins on monocytoid cells

Thrombosis and Haemostasis

Volumn 84, Issue 5, 2000, Pages 882-890

  Hawley, S B ^a   Green, M A ^a   Miles, L A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Fibrinolysis; Monocyte; Plasminogen; Receptor; U937

Indexed keywords

ACTIN; ANNEXIN; BINDING PROTEIN; CARBOXYPEPTIDASE B; CELL SURFACE PROTEIN; ENOLASE; PLASMINOGEN; RECEPTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL HETEROGENEITY; CELL MEMBRANE; CELL STRAIN U937; CELL SURFACE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HUMAN CELL; MONOCYTE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION;

EID: 0033678175     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614132     Document Type: Article

References (51)

1. The cell biology of the plasminogen system
2. Binding and activation of plasminogen on the platelet surface
3. Binding of plasminogen to cultured human endothelial cells
4. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor
5. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells
6. Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase
7. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin
8. Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding
9. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type
10. Plasminogen receptors in the mediation of pericellular proteolysis
11. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells
12. Binding of Lys-plasminogen to monocytes/macrophages
13. Plasminogen receptors, urokinase receptors and their modulation on human endothelial cells
14. Plasminogen-binding protein associated with the plasma membrane of cultured embryonic rat neocortical neurons
15. Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts
16. Plasminogen interacts with human platelets through two distinct mechanisms
17. Plasminogen receptors on rat colon carcinoma cells
18. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes. HepG2 cells and breast carcinoma cell lines
19. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells
20. 125I)-plasmin binding to colorectal carcinoma cells
21. Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis
22. Role of cell-surface lysines in plasminogen binding to cells: Identification of alpha-enolase as a candidate plasminogen receptor
23. Regulation of plasminogen receptor expression on monocytoid cells by beta1-integrin-dependent cellular adherence to extracellular matrix proteins
24. Limited proteolysis of tumor cells increases their plasmin-binding ability
25. The role of an enolase-related molecule in plasminogen binding to cells
26. Plasminogen binds specifically to alpha-enolase on rat neuronal plasma membrane
27. Purification of the plasmin receptor from human carcinoma cells and comparison to alpha-enolase
28. Alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci
29. Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation
30. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator
31. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II
32. Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a)
33. Actin accelerates plasmin generation by tissue plasminogen activator
34. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators
35. Plasminogen: Purification from human plasma by affinity chromatography
36. The cell-binding domains of plasminogen and their function in plasma
37. Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations
38. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
39. Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines
40. Two-dimensional gel electrophoresis of membrane proteins
41. A simplified two-dimensional electrophoretic technique
42. Methods for increasing the resolution of two-dimensional protein electrophoresis
43. Electrofocusing of integral membrane proteins in mixtures of zwitterionic and nonionic detergents
44. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
45. Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose
46. The erasable Western blot
47. Immunoassay of three enolase isozymes in human serum and in blood cells
48. Identification of neuron-specific enolase and nonneuronal enolase in human and rat brain on two-dimensional polyacrylamide gels
49. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
50. Cytokeratin expression in simple epithelia. III. Detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ
51. Competition between plasminogen and tissue plasminogen activator for cellular binding sites